Form 10-D UBS-Barclays Commercial For: May 12
http://archive.fast-edgar.com/20220524/AV2B422CZ222S2A222272CY295D5ZP22A242
Filed on: May 24, 2022
Form 6-K i-80 Gold Corp. For: May 24
http://archive.fast-edgar.com/20220524/AKZZKG2CZ22BKZZ2222N2ZZZQ9OAZZVS4242
Filed on: May 24, 2022
Form D Goat Investment Holdings
http://archive.fast-edgar.com/20220524/A622J22CX22222Z2222N224TKQCFL222B242
Filed on: May 24, 2022
Form 8-K MACROGENICS INC For: May 22
Exhibit 99.1MacroGenics Announces Appointment of William Heiden to Board of DirectorsROCKVILLE, MD, May 23, 2022 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today announced the appointment of William Heiden to its Board of Directors, effective May 22, 2022. Mr. Heiden will serve as Chair of the board and a member of the... (continue reading...)
Form 8-K P3 Health Partners Inc. For: May 18
Exhibit 99.1
P3 Health Partners Announces Receipt of Nasdaq Notice Regarding Late Filing of Periodic Reports
Henderson, NV, May 24, 2022 (GLOBE NEWSWIRE) -- P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that on May 18, 2022, it received a notice (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market ( “Nasdaq”)... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K CUTERA INC For: May 24
-
Form 8-K Enochian Biosciences For: May 24
-
Form DFAN14A New York City REIT, Inc. Filed by: Comrit Investments 1, LP
-
Form 6-K Agora, Inc. For: May 24
-
Form 6-K SciSparc Ltd. For: May 24
-
Form 8-K Kintara Therapeutics, For: May 20
-
Form 8-K WVS FINANCIAL CORP For: May 24
-
Form 6-K Dole plc For: Mar 31
-
Form 8-K Alaunos Therapeutics, For: May 24
-
Form 8-K RALPH LAUREN CORP For: May 24
-
Form 4 PARKE BANCORP, INC. For: May 23 Filed by: PENNONI CELESTINO R
-
Form S-8 ARTIVION, INC.
-
Form 8-K Blackstone Private Credi For: May 23
-
Form 8-K ALPINE IMMUNE SCIENCES, For: May 24
-
Form 8-K/A NAUTILUS, INC. For: May 23
-
Form 8-K DigitalOcean Holdings, For: May 23
-
Form 8-K Blackstone Secured Lendi For: May 23
-
Form SC 13G/A DUO WORLD INC Filed by: CANAGASOORYAM MUHUNTHAN
-
Form DEFA14A HASBRO, INC.
-
Form 8-K HomeTrust Bancshares, For: May 23
-
Form 425 PCSB Financial Corp Filed by: BROOKLINE BANCORP INC
-
Form 10-D COMM 2014-CCRE16 Mortgag For: May 12
-
Form 8-K Fisker Inc./DE For: May 24
-
Form 8-K MIMEDX GROUP, INC. For: May 24
-
Form 8-K BROOKLINE BANCORP INC For: May 23
-
Form 8-K GENOCEA BIOSCIENCES, For: May 20
-
Form 4 Compass Therapeutics, For: May 23 Filed by: Schuetz Thomas J.
-
Form DEF 14A EATON VANCE MUNICIPAL For: Jul 14 Filed by: EATON VANCE NEW YORK MUNICIPAL BOND FUND
-
Form SC 13D TDCX Inc. Filed by: Junique Laurent
-
Form 424B5 Fisker Inc./DE
-
Form 8-K SONO TEK CORP For: May 24
-
Form 8-K Rubius Therapeutics, For: May 20
-
Form 8-K SPAR Group, Inc. For: May 24
-
Form 424B3 Roivant Sciences Ltd.
-
Form 424B3 Roivant Sciences Ltd.
-
Form 8-K Piedmont Lithium Inc. For: May 24
-
Form DEFA14A Allena Pharmaceuticals,
-
Form SC 13D/A OLIN Corp Filed by: Sachem Head Capital Management LP
-
Form 424B3 Roivant Sciences Ltd.
-
Form DEF 14A Allena Pharmaceuticals, For: Jul 05
-
Form 10-K SONO TEK CORP For: Feb 28
-
Form 425 LMF Acquisition Opportun Filed by: LMF Acquisition Opportunities Inc
-
Form 8-K Moderna, Inc. For: May 24
-
Form 8-K Roivant Sciences Ltd. For: May 24
-
Form 4 ORASURE TECHNOLOGIES For: May 21 Filed by: Gleason Scott
-
Form 8-K QHSLab, Inc. For: May 24
-
Form DEFA14A PACIFIC BIOSCIENCES OF
-
Form SC 13G AIRGAIN INC Filed by: HIRSCHMAN ORIN
-
Form 8-K Zovio Inc For: May 23
-
Form 10-Q Sustainable Development For: Mar 31